Abstract/Details

The role of interleukin-10 in immune escape by a murine transitional cell carcinoma


2000 2000

Other formats: Order a copy

Abstract (summary)

Interleukin (IL)-10 is a potent immunosuppressive cytokine that is found in elevated quantities both at the tumor site and systemically in a variety of cancers. Given the potent suppressive properties of this cytokine, we hypothesized that its presence at the site of progressively growing tumors represents an immune escape mechanism utilized by tumors to avoid detection by the immune system. The thesis that follows examines issues related to this hypothesis.

We describe two features of a murine model of transitional cell carcinoma, MB49, that render it an attractive in vivo model with which to study the effect of IL-10 on tumor immunity. First, MB49 expresses the male antigen, H-Y. Thus, when grown in syngeneic female mice, H-Y provides a surrogate tumor-specific antigen for study. Second, MB49 does not produce IL-10 itself but rather induces infiltrating cells to produce IL-10. Consequently, growth of MB49 in IL-10 knockout (KO) mice, whose infiltrating cells are unable to produce IL-10, allows for the removal of the IL-10 normally associated with this tumor. Using MB49, we demonstrate that tumor-induced IL-10 inhibits the generation of a type I immune response against a tumor antigen as measured by Interferon (IFN)-γ production, cytotoxic T lymphocyte (CTL) generation, and delayed type hypersensitivity (DTH) reaction. Furthermore when tumor-induced IL-10 is removed, type 1 immunity is restored and tumors are completely rejected in up to 40 percent of animals.

Interestingly, during the course of these studies conflicting reports emerged in the literature regarding the effect of IL-10 in tumor systems. Those studying tumors engineered to produce IL-10 by way of gene-transfection uniformly reported that IL-10 enhances the anti-tumor immune response. In contrast, those studying IL-10 in tumor systems by other means consistently reported that IL-10 inhibits anti-tumor immunity. This led us to speculate that the method of study (i.e., gene-transfection vs. non gene-transfection) was the reason for the discrepancy. We addressed this hypothesis directly by transfecting MB49 with IL-10. We show that the disparate effects of IL-10 on tumor immunity are indeed due to the different modes of IL-10 production in the various studies.

In summary, our studies clearly demonstrate that IL-10 inhibits anti-tumor immunity. Furthermore, we provide a possible explanation for the discrepancy that exists concerning the role of this cytokine in tumor systems. These findings have important implications relative to the development of immunotherapy for the treatment of cancer.

Indexing (details)


Subject
Immunology;
Oncology
Classification
0982: Immunology
0992: Oncology
Identifier / keyword
Health and environmental sciences; Carcinoma; Immune escape; Interleukin-10; Transitional cell
Title
The role of interleukin-10 in immune escape by a murine transitional cell carcinoma
Author
Halak, Brian Keith
Number of pages
150
Publication year
2000
Degree date
2000
School code
0272
Source
DAI-B 61/02, Dissertation Abstracts International
Place of publication
Ann Arbor
Country of publication
United States
ISBN
0599678488, 9780599678484
Advisor
Lattime, Edmund C.
University/institution
Thomas Jefferson University
University location
United States -- Pennsylvania
Degree
Ph.D.
Source type
Dissertations & Theses
Language
English
Document type
Dissertation/Thesis
Dissertation/thesis number
9963617
ProQuest document ID
304642700
Copyright
Database copyright ProQuest LLC; ProQuest does not claim copyright in the individual underlying works.
Document URL
http://search.proquest.com/docview/304642700
Access the complete full text

You can get the full text of this document if it is part of your institution's ProQuest subscription.

Try one of the following:

  • Connect to ProQuest through your library network and search for the document from there.
  • Request the document from your library.
  • Go to the ProQuest login page and enter a ProQuest or My Research username / password.